ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,960 | -36.5% | 8,000 | -15.8% | 0.04% | -37.9% |
| Q2 2023 | $338,770 | -12.1% | 9,500 | 0.0% | 0.06% | -23.7% |
| Q4 2022 | $385,320 | +50.5% | 9,500 | +22.6% | 0.08% | +46.2% |
| Q3 2022 | $256,000 | -3.0% | 7,750 | +3.3% | 0.05% | 0.0% |
| Q2 2022 | $264,000 | -4.3% | 7,500 | +25.0% | 0.05% | +10.6% |
| Q1 2022 | $276,000 | -30.7% | 6,000 | 0.0% | 0.05% | -27.7% |
| Q4 2021 | $398,000 | +6.1% | 6,000 | 0.0% | 0.06% | -4.4% |
| Q3 2021 | $375,000 | +19.0% | 6,000 | +57.9% | 0.07% | +19.3% |
| Q2 2021 | $315,000 | +25.0% | 3,800 | 0.0% | 0.06% | +16.3% |
| Q1 2021 | $252,000 | -13.7% | 3,800 | 0.0% | 0.05% | -19.7% |
| Q4 2020 | $292,000 | +21.2% | 3,800 | 0.0% | 0.06% | -6.2% |
| Q4 2019 | $241,000 | – | 3,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |